PT692028E - Farmacos baseados em papilomavirus - Google Patents
Farmacos baseados em papilomavirusInfo
- Publication number
- PT692028E PT692028E PT94911252T PT94911252T PT692028E PT 692028 E PT692028 E PT 692028E PT 94911252 T PT94911252 T PT 94911252T PT 94911252 T PT94911252 T PT 94911252T PT 692028 E PT692028 E PT 692028E
- Authority
- PT
- Portugal
- Prior art keywords
- fragment
- formulation
- protein
- pct
- aluminum compound
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 7
- 239000000203 mixture Substances 0.000 abstract 7
- 239000012634 fragment Substances 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 241001631646 Papillomaviridae Species 0.000 abstract 4
- 229910052782 aluminium Inorganic materials 0.000 abstract 4
- -1 aluminum compound Chemical class 0.000 abstract 4
- 241000701822 Bovine papillomavirus Species 0.000 abstract 2
- 241000701812 Bovine papillomavirus type 4 Species 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 2
- 230000003902 lesion Effects 0.000 abstract 2
- 230000003053 immunization Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306731A GB9306731D0 (en) | 1993-03-31 | 1993-03-31 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT692028E true PT692028E (pt) | 2003-10-31 |
Family
ID=10733089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94911252T PT692028E (pt) | 1993-03-31 | 1994-03-31 | Farmacos baseados em papilomavirus |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6020309A (pt) |
| EP (1) | EP0692028B1 (pt) |
| JP (1) | JPH08508728A (pt) |
| AT (1) | ATE242265T1 (pt) |
| AU (1) | AU6381794A (pt) |
| CA (1) | CA2158554A1 (pt) |
| DE (1) | DE69432790T2 (pt) |
| DK (1) | DK0692028T3 (pt) |
| ES (1) | ES2199960T3 (pt) |
| GB (1) | GB9306731D0 (pt) |
| PT (1) | PT692028E (pt) |
| WO (1) | WO1994023037A1 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM358894A0 (en) * | 1994-01-31 | 1994-02-24 | Csl Limited | Modified papilloma virus l2 protein and vlps formed therefrom |
| FR2751879B1 (fr) * | 1996-07-30 | 1998-10-30 | Transgene Sa | Composition pharmaceutique contre les tumeurs et infections a papillomavirus |
| US7118754B1 (en) | 1996-07-30 | 2006-10-10 | Transgene S.A. | Pharmaceutical composition for treating papillomavirus tumors and infection |
| AU781653B2 (en) * | 1996-07-30 | 2005-06-02 | Transgene S.A. | Pharmaceutical composition for treating papollomavirus tumour and infection |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| US20020039584A1 (en) | 1998-02-20 | 2002-04-04 | Medigene Ag | Papilloma virus capsomere vaccine formulations and methods of use |
| US7182947B2 (en) | 1998-02-20 | 2007-02-27 | Medigene Ag | Papillomavirus truncated L1 protein and fusion protein constructs |
| CA2229955C (en) | 1998-02-20 | 2003-12-09 | Medigene Gmbh | Papilloma virus capsomere vaccine formulations and methods of use |
| US7494658B2 (en) | 1998-02-20 | 2009-02-24 | Medigene Ag | Papilloma virus truncated L1 protein and fusion protein constructs |
| US6926897B1 (en) | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
| US8128922B2 (en) * | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| KR100366608B1 (ko) * | 2000-02-15 | 2003-01-09 | 마스터진(주) | 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신 |
| EP1305039B1 (en) * | 2000-07-06 | 2008-12-31 | Georgetown University | Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof |
| AU2001290520A1 (en) * | 2000-08-01 | 2002-02-13 | The Johns Hokpins University | Intercellular transport protein linked to an antigen as a molecular vaccine |
| CA2417214C (en) * | 2000-08-03 | 2016-06-21 | Johns Hopkins University | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| EP1644048B1 (en) * | 2003-05-05 | 2015-04-29 | Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| AU2005322960A1 (en) * | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines |
| EP1846026A4 (en) * | 2005-01-26 | 2008-07-02 | Univ Johns Hopkins | ANTICANCER DNA VACCINE USING PLASMID CODING ANTIGEN AND CALRETICULIN SUCH AS MUTANT ONCOPROTEINS |
| JP5224821B2 (ja) | 2005-02-01 | 2013-07-03 | アメリカ合衆国 | 広範に交差中和する抗体を誘導するためのパピローマウイルスｌ２ｎ末端ペプチド |
| WO2008024844A2 (en) * | 2006-08-22 | 2008-02-28 | The Johns Hopkins University | Anticancer combination therapies |
| US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
| US20080260765A1 (en) * | 2007-03-15 | 2008-10-23 | Johns Hopkins University | HPV DNA Vaccines and Methods of Use Thereof |
| US20090285861A1 (en) * | 2008-04-17 | 2009-11-19 | Tzyy-Choou Wu | Tumor cell-based cancer immunotherapeutic compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0133123A1 (en) * | 1983-07-25 | 1985-02-13 | Mgi Pharma, Inc. | Immunogens of papilloma viruses |
| US5180806A (en) * | 1988-05-16 | 1993-01-19 | The Scripps Research Institute | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| FR2641081A1 (pt) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
| AU8762991A (en) * | 1990-09-26 | 1992-04-15 | Bristol-Myers Squibb Company | Human papilloma viral protein expression for use in vaccine compositions |
| GB9113809D0 (en) * | 1991-06-26 | 1991-08-14 | Cancer Res Campaign Tech | Papillomavirus l2 protein |
| DK0595935T3 (da) * | 1991-07-19 | 2003-07-21 | Csl Ltd | Papillomavirusvaccine |
| GB9207701D0 (en) * | 1992-04-08 | 1992-05-27 | Cancer Res Campaign Tech | Papillomavirus e7 protein |
-
1993
- 1993-03-31 GB GB939306731A patent/GB9306731D0/en active Pending
-
1994
- 1994-03-31 US US08/525,764 patent/US6020309A/en not_active Expired - Fee Related
- 1994-03-31 DE DE69432790T patent/DE69432790T2/de not_active Expired - Fee Related
- 1994-03-31 CA CA002158554A patent/CA2158554A1/en not_active Abandoned
- 1994-03-31 WO PCT/GB1994/000683 patent/WO1994023037A1/en active IP Right Grant
- 1994-03-31 DK DK94911252T patent/DK0692028T3/da active
- 1994-03-31 JP JP6521838A patent/JPH08508728A/ja not_active Ceased
- 1994-03-31 ES ES94911252T patent/ES2199960T3/es not_active Expired - Lifetime
- 1994-03-31 AT AT94911252T patent/ATE242265T1/de not_active IP Right Cessation
- 1994-03-31 PT PT94911252T patent/PT692028E/pt unknown
- 1994-03-31 EP EP94911252A patent/EP0692028B1/en not_active Expired - Lifetime
- 1994-03-31 AU AU63817/94A patent/AU6381794A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2199960T3 (es) | 2004-03-01 |
| DE69432790T2 (de) | 2004-04-22 |
| DK0692028T3 (da) | 2003-09-29 |
| WO1994023037A1 (en) | 1994-10-13 |
| GB9306731D0 (en) | 1993-05-26 |
| ATE242265T1 (de) | 2003-06-15 |
| AU6381794A (en) | 1994-10-24 |
| DE69432790D1 (de) | 2003-07-10 |
| EP0692028B1 (en) | 2003-06-04 |
| EP0692028A1 (en) | 1996-01-17 |
| JPH08508728A (ja) | 1996-09-17 |
| CA2158554A1 (en) | 1994-10-13 |
| US6020309A (en) | 2000-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT692028E (pt) | Farmacos baseados em papilomavirus | |
| EP0784471A4 (en) | FACET-FITTED METHOD FOR SUPPRESSING THE REPRODUCTION OF LATEN VIRUSES IN HUMANS AND ANIMALS | |
| DE69705300T2 (de) | Cyclopropylalkansäurederivate | |
| ITMI922699A1 (it) | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione | |
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| MX9701538A (es) | Sales de un derivado del indol contra la migraña. | |
| ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| ES2172572T3 (es) | Emulsion farmaceutica. | |
| RU94044436A (ru) | Способы подавления атрофии кожи и влагалища | |
| CA2258217A1 (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
| ATE171066T1 (de) | Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält | |
| NO972623L (no) | Farmasöytisk blanding omfattende lamotrigin | |
| ES2122015T3 (es) | Uso de urodilatina en enfermedades pulmonares y bronquiales. | |
| DE69629195D1 (de) | Inhibitor von gehirnödemen | |
| DE69302677T2 (de) | Liposomale piroxycam formulierung | |
| FI934680A (fi) | Arylmorfolin, framstaellning och anvaending | |
| DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
| SE9401596D0 (sv) | New compounds | |
| PL318539A1 (en) | Inhibition of biosynthesis | |
| DE69400908T2 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden | |
| NO306673B1 (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse |